Information
-
Trademark
-
88074194
-
Serial Number
88074194
-
Registration Number
6031814
-
International Classifications
-
Filing Date
August 10, 2018
6 years ago
-
Registration Date
April 14, 2020
4 years ago
-
Transaction Date
June 17, 2024
7 months ago
-
Status Date
April 14, 2020
4 years ago
-
Published for Opposition Date
July 16, 2019
5 years ago
-
Location Date
April 14, 2020
4 years ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
INGOLD, GERALDINE
-
Attorney Docket Number
2854-T400US
Attorney Name
Frances M. Jagla
Law Office Assigned Location Code
N30
-
Owners
Mark Drawing Code
4
Mark Identification
MONJUVI
Case File Statements
- GS0051: Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines for use in the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; none of the foregoing goods for use in connection with the treatment or prevention of ear disorders
- GS0421: Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies
Case File Event Statements
-
11/15/2018 - 6 years ago
6 - TEAS VOLUNTARY AMENDMENT RECEIVED
Type: PARI
-
8/14/2018 - 6 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
8/20/2018 - 6 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
9/9/2018 - 6 years ago
3 - TEAS VOLUNTARY AMENDMENT RECEIVED
Type: PARI
-
9/18/2018 - 6 years ago
4 - ASSIGNED TO LIE
Type: ALIE
-
9/18/2018 - 6 years ago
5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Type: AMPX
-
11/20/2018 - 6 years ago
7 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Type: AMPX
-
11/28/2018 - 6 years ago
8 - ASSIGNED TO EXAMINER
Type: DOCK
-
12/4/2018 - 6 years ago
9 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
12/4/2018 - 6 years ago
10 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
12/4/2018 - 6 years ago
11 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
5/31/2019 - 5 years ago
12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
5/31/2019 - 5 years ago
13 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
6/1/2019 - 5 years ago
14 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
6/10/2019 - 5 years ago
17 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
6/10/2019 - 5 years ago
16 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
7/16/2019 - 5 years ago
21 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
6/10/2019 - 5 years ago
15 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
6/10/2019 - 5 years ago
18 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
6/12/2019 - 5 years ago
19 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
6/26/2019 - 5 years ago
20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
10/22/2019 - 5 years ago
24 - TEAS POST PUBLICATION AMENDMENT RECEIVED
Type: EPPA
-
7/16/2019 - 5 years ago
22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
7/22/2019 - 5 years ago
23 - EXTENSION OF TIME TO OPPOSE RECEIVED
Type: ETOF
-
11/20/2019 - 5 years ago
26 - CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Type: CHPB
-
11/18/2019 - 5 years ago
25 - ASSIGNED TO PETITION STAFF
Type: APET
-
1/13/2020 - 5 years ago
27 - OPPOSITION INSTITUTED NO. 999999
Type: OP.I
-
3/7/2020 - 4 years ago
29 - OPPOSITION TERMINATED NO. 999999
Type: OP.T
-
3/7/2020 - 4 years ago
30 - TTAB RELEASE CASE TO TRADEMARKS
Type: TMBN
-
3/7/2020 - 4 years ago
28 - OPPOSITION DISMISSED NO. 999999
Type: OP.D
-
4/14/2020 - 4 years ago
31 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
6/17/2024 - 7 months ago
35 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Type: CHAN
-
6/17/2024 - 7 months ago
34 - TEAS CHANGE OF OWNER ADDRESS RECEIVED
Type: COAR
-
6/17/2024 - 7 months ago
37 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
6/17/2024 - 7 months ago
36 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
6/17/2024 - 7 months ago
38 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
5/1/2024 - 9 months ago
33 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Type: ASGN
-
4/24/2024 - 9 months ago
32 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Type: ASCK